Chest Imaging, Breath, and Biomarkers in a Screening Trial
NCT ID: NCT01663155
Last Updated: 2017-05-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1424 participants
OBSERVATIONAL
2008-09-30
2014-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Next Generation Chest X-Ray Tomosynthesis for Screening of Lung Cancer
NCT06577883
A Study of Lung Cancer Screening in People With Unexplained Weight Loss
NCT06717334
Lung Cancer Screening Study With Low-dose CT Scan and Blood Biomarker
NCT01700257
Screening Methods in Finding Lung Cancer Early in Current or Former Smokers
NCT00751660
Chest X-Ray or Chest CT Scan in Patients at High Risk of Developing Lung Cancer
NCT00006087
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
all enrolled subjects
Intervention is chest x-ray and CT scan. The chest x-ray image is read first without computer aided detection (CAD) and then a second time with computer aided detection (CAD) the CT scan is read by one reader. Subjects are asked to contribute breath and blood samples.
chest x-ray with or without CAD, lose dose CT scan
PA view, low dose CT scan
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
chest x-ray with or without CAD, lose dose CT scan
PA view, low dose CT scan
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* If ages 40-59, then one of the following criteria needs to be met:
* Current or ex-smoker with \>25 pack years and a family history of lung cancer(parent or sibling) OR
* current or ex-smoker with \> 25 pack years and COPD OR
* current or ex-smoker with a \> 35 pack year history
* If ages 60-75, then one of the following additional criteria needs to be met:
* Current or ex-smoker with \>25 pack years and a family history of lung cancer (parent or sibling) OR
* Current or ex-smoker with \>25 pack years and COPD OR
* Current or ex-smoker with a \>30 pack year history
* Subject is able to return to Cleveland Clinic for annual follow-up screening
* Subject is willing to sign a medical release form
Exclusion Criteria
* Have had a chest x-ray or CT of the chest within the last 6 months
* Previous pneumonectomy
* Lobectomy of the lung within the last 5 years
* Diagnosed malignancy within the last 5 years, excluding non-melanoma skin cancer, carcinoma in situ of the cervix and localized prostate cancer
* A medical condition that would prevent treatment for lung cancer
* Within the last 6 weeks, one of the following has occured:
* A new cough or chronic cough that has gotten worse
* Either new shortness of breath, or any worsening of shortness of breath
* A cough producing blood
* Constant chest pain
* Respiratory infection, pneumonia, or cold
* Unintentional and unexplained weight loss greater than 5% of total body weight
40 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Cleveland Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Moulay Meziane, MD
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Micheal Phillips, M.D.
Role: STUDY_CHAIR
The Cleveland Clinic
Moulay Meziane, MD
Role: PRINCIPAL_INVESTIGATOR
Chair of Thoracic Imaging
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cleveland Clinic
Cleveland, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Mazzone PJ, Obuchowski N, Fu AZ, Phillips M, Meziane M. Quality of life and healthcare use in a randomized controlled lung cancer screening study. Ann Am Thorac Soc. 2013 Aug;10(4):324-9. doi: 10.1513/AnnalsATS.201301-007OC.
Mazzone PJ, Obuchowski N, Phillips M, Risius B, Bazerbashi B, Meziane M. Lung cancer screening with computer aided detection chest radiography: design and results of a randomized, controlled trial. PLoS One. 2013;8(3):e59650. doi: 10.1371/journal.pone.0059650. Epub 2013 Mar 20.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
State of Ohio grant
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
06-055
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
07-455
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.